The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.07.026 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Kazuki Sakurai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tohoku University Hospital, Sendai, Japan. Hauptthemen laut MEDLINE: Cord Blood Stem Cell Transplantation, Core Binding Factor Alpha 2 Subunit, Leukemia, Myeloid, Acute, RUNX1 Translocation Partner 1 Protein. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Acute myeloid leukemia (AML) with RUNX1::RUNX1T1 usually has a favorable outcome. However, it sometimes relapses and is refractory; in these cases, allogeneic hematopoietic stem cell transplantation (HSCT) is indicated. When HLA-matched sibling donors (MSDs) are unavailable, alternative donor sources, such as unrelated umbilical cord blood cells (UCB), are considered. However, the outcomes of UCB for AML with RUNX1::RUNX1T1 have not yet been fully examined. We retrospectively analyzed the outcomes of HSCT with UCB. METHODS: A total of 12 patients with AML with RUNX1::RUNX1T1 who received UCB transplantation between 2002 and 2022 in 3 transplantation centers in Miyagi Prefecture were included. The median age at transplantation was 32 years; ten patients chose myeloablative conditioning regimens, and 9 patients achieved complete remission just before HSCT. RESULTS: The 3-year overall survival and relapse-free survival were both 75.0%. All patients in complete remission (CR) before HSCT remained in remission during follow-up. The cumulative incidence of 3-year non-relapse mortality was 16.7%. CONCLUSION: These results indicate that UCB transplantation could be a feasible option for patients with relapse/refractory RUNX1::RUNX1T1-positive AML without MSDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Tohoku University Hospital, Sendai, Japan.
- Department of Hematology, Tohoku University Hospital, Sendai, Japan; Department of Hematology, NHO Sendai Medical Center, Sendai, Japan. Electronic address: hiyokoyam@gmail.com.
- Department of Hematology, Tohoku University Hospital, Sendai, Japan; Department of Hematology, Miyagi Cancer Center, Natori, Japan.
- Department of Hematology, Tohoku University Hospital, Sendai, Japan; Department of Hematology, NHO Sendai Medical Center, Sendai, Japan.
- Department of Hematology, NHO Sendai Medical Center, Sendai, Japan.
- Department of Hematology, Miyagi Cancer Center, Natori, Japan.
Zitieren
APA
Sakurai, K., Yokoyama, H., Komatsu, H., Takenaka, K., Narumi, Y., Hatta, S., Onodera, K., Fukuhara, N., Onishi, Y., Katsuoka, Y., Saito, Y., Kamata, M., Harazaki, Y., Tomiya, Y., Izumi, T., Sasaki, O., & Harigae, H. (2026). The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.07.026
Vancouver
Sakurai K, Yokoyama H, Komatsu H, Takenaka K, Narumi Y, Hatta S, et al. The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.07.026
BibTeX
@article{Sakurai2026,
author = {Sakurai, Kazuki and Yokoyama, Hisayuki and Komatsu, Hiroka and Takenaka, Kenta and Narumi, Yoshihiro and Hatta, Shunsuke and Onodera, Koichi and Fukuhara, Noriko and Onishi, Yasushi and Katsuoka, Yuna and Saito, Yo and Kamata, Mayumi and Harazaki, Yoriko and Tomiya, Yasuo and Izumi, Toru and Sasaki, Osamu and Harigae, Hideo},
title = {The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.07.026}
}
EUVIMED